Ministry of Health and Family Welfare:
Dr. Harsh Vardhan, Union Minister of Health & Family Welfare chaired the 25th meeting of the high-level Group of Ministers (GoM) on COVID-19 through video-conference, here today.
He was joined by Dr S. Jaishankar, Minister of External Affairs, Sh. Hardeep S. Puri, Minister of Civil Aviation, Shri Mansukh Mandaviya, Minister of State for Ports, Shipping and Waterways (I/C), & Chemical and Fertilizers, and Sh. Nityanand Rai, Minister of State, Ministry of Home Affairs. Sh. Ashwini Kumar Choubey, Minister of State, Health & Family Welfare joined digitally.
Dr. Vinod K Paul, Member (Health), NITI Aayog was present virtually.
At the outset, Dr Harsh Vardhan apprised other members of GOM about the steadily growing trajectory of daily recoveries.
There are more than 3 lakh recoveries in the last 24 hours, he stated.
He also observed that “180 districts have showed no fresh cases in the last 7 days, 18 districts in 14 days, 54 districts in 21 days and 32 districts were bereft of any fresh cases in the last 28 days.”
The number of patients in ICU beds is 4,88,861 while 1,70,841 patients and 9,02,291 patients are on ventilator and oxygen support, he added.
This translates to 1.34% of COVID caseload being in ICU, 0.39% of cases on ventilators and 3.70% of COVID patients on oxygen as on date.
Dr Harsh Vardhan informed the GOM that, “the cumulative number of COVID19 vaccine doses administered in the country has crossed 16.73 Cr today which includes nearly 23 lakh doses given yesterday.
A total of 17,49,57,770 doses have been delivered to the states, out of which 16,65,49,583 doses have been consumed and 84,08,187 doses are still available with the states.
He further added that a total of 53,25,000 doses are on the pipeline and will be supplied to the states soon.
Reiterating the importance of full protection through two COVID Vaccine doses, he again appealed to all citizens to get the second dose which boosts the immunity against COVID manifold.
He requested the States to set aside 70% of the vaccines received through GoI channel for administration of the second dose.
On the tests being conducted in India, the Union Health Minister noted that the country has reached a testing capacity of 25,00,000 tests per day.
He informed that a total of 30,60,18,044 tests have been conducted so far in India, which includes 18,08,344 tests in the last 24 hours.
From just one lab at NIV Pune, the country is presently served by 2,514 labs.
Dr Sujeet Kumar Singh, Director, National Centre for Disease Control (NCDC) highlighted the COVID trajectory of India vis-a-vis that of other countries.
He underscored the need and importance of significantly ramping up testing and hospital infrastructure in Tier-II/III cities in view of the surge in cases which has seen a shift to these regions/areas too.
States of Maharashtra (1.27%), Karnataka (3.05%), Kerala (2.35%), Uttar Pradesh (2.44%), Tamil Nadu (1.86%), Delhi (1.92%), Andhra Pradesh (1.90%), West Bengal (2.19%), Chhattisgarh (2.06%), Rajasthan (2.99%), Gujarat (2.40%), Madhya Pradesh (2.24%) were highlighted because of their high 7 day growth rate in cases.
The districts/metropolis of Bengaluru (Urban), Ganjam, Pune, Delhi, Nagpur, Mumbai, Ernakulam, Lucknow, Kozhikode (Calicut), Thane, Nashik, Malappuram, Thrissur, Jaipur, Gurgaon, Chennai, Thiruvananthapuram, Chandrapur, Kolkata, Palakkad are the top 20 contributors of Active Cases in the country.
Ministry of Defence:
An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad.
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients. The drug will be of immense benefit to the people suffering from COVID-19.
Pursuing Prime Minister Shri Narendra Modi’s call for preparedness against the pandemic, DRDO took the initiative of developing anti-COVID therapeutic application of 2-DG. In April 2020, during the first wave of the pandemic, INMAS-DRDO scientists conducted laboratory experiments with the help of Centre for Cellular and Molecular Biology (CCMB), Hyderabad and found that this molecule works effectively against SARS-CoV-2 virus and inhibits the viral growth.
Based on these results, Drugs Controller General of India’s (DCGI) Central Drugs Standard Control Organization (CDSCO) permitted Phase-II clinical trial of 2-DG in COVID-19 patients in May 2020.
The DRDO, along with its industry partner DRL, Hyderabad, started the clinical trials to test the safety and efficacy of the drug in COVID-19 patients. In Phase-II trials (including dose ranging) conducted during May to October 2020, the drug was found to be safe in COVID-19 patients and showed significant improvement in their recovery.
Phase IIa was conducted in six hospitals and Phase IIb (dose ranging) clinical trial was conducted at 11 hospitals all over the country. Phase-II trial was conducted on 110 patients.
In efficacy trends, the patients treated with 2-DG showed faster symptomatic cure than Standard of Care (SoC) on various endpoints.
A significantly favourable trend (2.5 days difference) was seen in terms of the median time to achieving normalisation of specific vital signs parameters when compared to SoC.
Based on successful results, DCGI further permitted the Phase-III clinical trials in November 2020. The Phase-III clinical trial was conducted on 220 patients between December 2020 to March 2021 at 27 COVID hospitals in Delhi, Uttar Pradesh, West Bengal, Gujarat, Rajasthan, Maharashtra, Andhra Pradesh, Telangana, Karnataka and Tamil Nadu.
The detailed data of phase-III clinical trial was presented to DCGI. In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by Day-3 in comparison to SoC, indicating an early relief from Oxygen therapy/dependence.
The similar trend was observed in patients aged more than 65 years. On May 01, 2021, DCGI granted permission for Emergency Use of this drug as adjunct therapy in moderate to severe COVID-19 patients.
Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty in the country.
The drug comes in powder form in sachet, which is taken orally by dissolving it in water. It accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique.
In the ongoing second COVID-19 wave, a large number of patients are facing severe oxygen dependency and need hospitalisation. The drug is expected to save precious lives due to the mechanism of operation of the drug in infected cells. This also reduces the hospital stay of COVID-19 patients.
Ministry of Health and Family Welfare:
In a significant directive to the States, Union Ministry of Health and Family Welfare has revised the national policy for admission of COVID patients to various categories of COVID facilities.
This patient-centric measure aims to ensure prompt, effective and comprehensive treatment of patients suffering from COVID19.
As per the Union Government directive to all States and UTs, hospitals under the Central government, State Governments and Union Territory administration including private hospitals (in States and Union Territories) managing COVID Patients shall ensure the following:
- Requirement of a positive test for COVID-19 virus is not mandatory for admission to a COVID health facility. A suspect case shall be admitted to the suspect ward of CCC, DCHC or DHC as the case may be.
- No patient will be refused services on any count. This includes medications such as oxygen or essential drugs even if the patient belongs to a different city.
- No patient shall be refused admission on the ground that he/she is not able to produce a valid identity card that does not belong to the city where the hospital is located.
- Admissions to hospital must be based on need. It should be ensured that beds are not occupied by persons who do not need hospitalization. Further, the discharge should be strictly in accordance with the revised discharge policy available at https://www.mohfw.gov.in/pdf/ReviseddischargePolicyforCOVID19.pdf
Union Health Ministry has advised the Chief Secretaries of States/Union territories to issue necessary orders and circulars, incorporating the above directions within three days, which shall be enforced till replaced by an appropriate uniform policy.
The Health Ministry has earlier enunciated a policy of setting up three tier health infrastructure for appropriate management of suspect/confirmed COVID-19 cases. The guidance document issued in this regard on 7th April 2020, envisages setting up of:
- COVID Care Center (CCC) that shall offer care for mild cases. These have been set up in hostels, hotels, schools, stadiums, lodges etc., both public and private. Functional hospitals like CHCs, etc. which may be handling regular, non-COVID cases may also be designated as COVID Care Centres as a last resort.
- Dedicated COVID Health Centre (DCHC) that shall offer care for all cases that have been clinically assigned as moderate. These should either be a full hospital or a separate block in a hospital with preferably separate entry/exit/zoning. Private hospitals may also be designated as COVID Dedicated Health Centres. These hospitals would have beds with assured Oxygen support.
- Dedicated COVID Hospital (DCH) that shall offer comprehensive care primarily for those who have been clinically assigned as severe. These hospitals should either be a full hospital or a separate block in a hospital with preferably separate entry/exit. Private hospitals may also be designated as COVID Dedicated Hospitals. These hospitals would have fully equipped ICUs, Ventilators and beds with assured Oxygen support.
The above mentioned COVID health infrastructure has been aligned with clinical management protocol for admission of mild cases to CCC, moderate cases to DCHC and severe cases to DCH.
MK Stalin – CM, Tamil Nadu:
Spoke to PM Narendra Modi over the phone and explained to him the preventive measures being taken by the State Govt. against Covid19 and sought the Union Govt’s cooperation.
PM assured that he will consider Tamil Nadu’s request for allocation of more Oxygen.
Delhi has received only 487MT oxygen yesterday. Which is much less then the current need of approx 700MT.manish sisodia – dy cm, delhi
With this deficit it would be hard to manage proper supply for all hospitals.
We urge Central govt to provide us 700 MT oxygen daily as directed by Hon SC.
Appreciate the gesture of Texas Instruments IN to set up a modular ICU unit with 86 critical care beds at RGICD, Bengaluru through its CSR initiative.BS Yediyurappa – cm, karnataka
I urge corporates to partner with the government to boost healthcare capacities and strengthen the battle against the pandemic.
Sukhbir Singh Badal – President, Akali Dal:
- I commend the SGPC for dedicating a 50-bed Covid Care centre today at Takht Sri Damdama Sahib, Talwandi Sabo.
- This free of cost facility will be manned by 32 medical personnel round the clock.
- Earlier, the SGPC had opened a 25-bed care centre at Alamgir in Ludhiana on Thursday.
- I appeal to SGPC head Bibi Jagir Kaur Ji to import vaccines & also urge Covid patients to reach a hospital at the earliest to avoid complications.
- It’s unfortunate that Punjab govt failed to upgrade & substantiate medical infra.
- I urge CM to cap astronomical charges by private hospitals.
Checked the preparedness at All India Institute of Ayurveda.kiren rijiju – union minister
Ayush Ministry has advised to induct 8 lakh trained Ayush professionals for COVID19 duties.
Ministry will support States/ UTs to convert 750 Ayush Medical Colleges for Covid-19 care thus adding 50,000 beds.
Spoke on phone to young Vansh Singh, aged 10, a Class II dropout who’s video I saw selling socks at traffic crossing in Ludhiana.capt amarinder singh
Have asked the DC to ensure he rejoins his school.
Also announced an immediate financial assistance of Rs 2 lakhs to his family.
Meghalaya Govt. has decided to continue the Lockdown in East Khasi Hills district till 5 AM of 17th May 2021.conrad sangma – cm, meghalaya
However, few restrictions will be lifted during the period.
Essential Commodities’ shops in localities regulated by the Dorbar Shnong will be open with strict adherence to SOPs.
Aaditya Thackeray – Minister, Maharashtra Govt.:
- We value the services of our health warriors who have kept duty above self.
- Discussed with BMC Municipal Commissioner Chahal ji yesterday. Today he has informed me that the concerns of the resident docs have been addressed, the arrears will be released this week. We are all together in this.
- I’m grateful to Municipal Commissioner Iqbal Singh Chahal ji, AMC Health Kakani ji for their instant intervention on my humble request. Last year too, we had a meeting with resident docs on some issues that were sorted immediately.
- The Mumbai Mayor Kishori Pednekar ji, my colleague and guardian minister of Mumbai City Aslam Shaikh ji and I are constantly working to fulfil our commitment of doing the best for our city and guardian districts together with all citizens as a team.
With a resolve to vaccinate all of Delhi within three months, CM Arvind Kejriwal appeals to the central govt for speedy & bulk supply of vaccines.Atishi – AAP leader
By tripling Delhi govt school centers for free vaccinations, we may be able to protect Delhi from next wave of COVID19.